Author: Steve Geffon, Chief Commercial Officer
Snapshot:
- Suvoda and Greenphire merger changes the game: With the merger complete, Suvoda is creating a roadmap for a unified platform to ease the clinical trial journey for all stakeholders.
- Eight products on one platform: Combined solutions unify randomization, consent, patient outcomes, data collection, payments, travel logistics, scheduling, and more on a single platform.
- Benefits across stakeholder groups: Patients find it easier to participate, sites manage studies with less complexity, and sponsors get clearer data to guide decisions.
In my nearly 20 years working with clinical trials, I’ve seen how timelines can determine success. Patients need timely reimbursement after visits. Sites must manage complex, time-sensitive drug supply logistics and financial workflows. Sponsors require real-time visibility across enrollment, payments, and outcomes data. These critical moments demand technology that works seamlessly.
The merger of Suvoda and Greenphire supports these time-sensitive moments, helping trials run efficiently while keeping the experience straightforward for everyone involved.
Meeting the challenge of growing trial complexity
Clinical trials are becoming increasingly complex, yet patients and sites expect—and deserve—simpler, more intuitive experiences.
Suvoda has historically specialized in what I view as the central nervous system of trials: randomization, supply management, consent, and patient outcomes data collection for studies. Greenphire has focused on the vital need to remove financial barriers and logistical obstacles for patients and sites.
Our merger creates something unique: a truly integrated platform that bridges these two areas of expertise, balancing trial complexity with simplicity for users.
The strength of cohesive solutions
The patented Suvoda Platform unifies a suite of solutions and provides visibility and insight to sponsors, sites, and patients so they can make more informed decisions about the clinical trial.
The platform brings together eight products: IRT, eCOA, eConsent, Greenphire Patient Payments, Greenphire Travel, Scheduling, Site Payments and Budgeting & Benchmarking. I've seen how fragmented systems create unnecessary friction for all stakeholders, but our end-to-end platform addresses that challenge head on.
By streamlining the trial experience, our hope is that patients will be more engaged and stay in their trial. We want site teams to feel more supported so they can focus on their patients instead of technology. And, we want sponsors to realize efficiencies and reduced vendor complexity so that perhaps they can bring their investigational product to market faster.
We think the Suvoda Platform delivers value in two key ways:
Streamlined workflows ease the experience
The Suvoda Platform brings together essential trial tools in one place, with connections and workflows happening without added human intervention.
Imagine, for example, a scenario where a patient’s eligibility is assessed automatically in IRT using the latest eCOA outcomes data. Then, if eligible, the patient is randomized into the study. The patient is prompted to self-schedule a visit with travel options available to meet their needs. After they complete their visit, they can submit their visit expenses for reimbursement—all within an easy-to-use app.
In addition to smoothing the patient journey, we think about the needs of site and sponsor teams, who are critical to a trial’s success. We are working to ease their administrative workload through the use of AI tools, like our assistant Sofia. We are also providing a single sign on, a shared data layer that decreases integrations and the manual entry of information, an intuitive interface across products, and a dedicated support team that's ready if needed. Sponsors can enjoy fewer vendors to manage, a shared backend data layer for quick visibility to trial information, and satisfied sites who see them as a vendor of choice.
Connected data powers more informed decision making
The interconnected data layer provides sponsors with data visibility and integrity across the most urgent moments of the clinical trial. Unified data for site enrollment, patient randomization, eCOA compliance, patient payments, and site budgetary actuals give sponsors comprehensive insight into trial performance in real-time.
What this means for patients, sites, and sponsors
Each group involved in clinical trials gains distinct advantages from this unified approach. What I see as the most significant improvements from this deploying this strategy are:
Patients and their caregivers benefit from a more seamless experience
The unified platform reduces barriers that make trial participation difficult, creating peace amidst the stress, and allowing patients to focus on their treatment.
Consider a patient finishing their randomization visit. They receive an invitation to download the Suvoda App, which can manage their entire trial journey from travel to answering questionnaires or submitting daily symptom diaries. As the trial progresses, automated appointment reminders, travel booking, and timely stipend payments eliminate common frustrations. When completing scheduled visits, the system can even process stipends automatically.
Sites operate with reduced complexity
For sites, the combined company's robust and unified set of solutions will reduce operational complexity, streamline essential work like drug supply management and financial management, and ease delivery of patient care.
When a patient arrives for a visit, site staff can handle everything from confirming consent and randomizing patients to managing drug dispensing and coordinating outcomes assessments from the same platform. This reduces training requirements, minimizes data entry errors, and allows clinical staff to focus more on patient care.
Innovations in AI like Sofia can help site staff or drug supply managers find information easily, reducing burden through a seamless, intuitive workflow.
Sponsors and CROs gain comprehensive solutions
Sponsors and CROs will have a suite of solutions that reduce trial complexity and deliver data-driven insight from a single provider. That can help drive patient retention, site satisfaction, and trial efficiency, so results can ideally be submitted for approval faster.
Real-time reporting will show enrollment rates, payment status, and outcome compliance. Integrated financial and operational data helps with proactive intervention when problems arise and supports more adaptive trial designs.
In short, our unified Platform fundamentally changes how clinical trials operate by addressing the needs of every stakeholder.
A new horizon for clinical trials
After years of watching our industry struggle with fragmented systems that create unnecessary challenges, I believe Suvoda will improve how we conduct clinical research. We have the potential to address pain points I've witnessed throughout my career in ways that individual solutions may not be able to achieve. Our platform and our investment in AI can help reduce timelines, improve delivery, and enable sites and sponsors to access critical study data quickly.
I’m excited to be a part of this new stage in clinical trials. Soon, our customers will be able to experience how the unified Suvoda Platform delivers reliably, helping accelerate life-changing treatments and keeping the clinical trials journey straightforward for everyone involved.
Authors
Steve Geffon
Chief Commercial Officer,
Suvoda
EBOOK
Increase patient engagement using the latest innovations in eClinical technologies.